August 01, 2019 – Alexandra Guadagno
August 01, 2019 – Kristie L. Kahl
July 31, 2019 – Jessica Skarzynski
July 31, 2019 – Kristie L. Kahl
July 31, 2019 – Kristie L. Kahl
July 30, 2019 – Kristie L. Kahl
July 29, 2019 – Kristie L. Kahl
July 26, 2019 – Alexandra Guadagno
July 26, 2019 – Kristie L. Kahl
CURE's Top 5 Stories: July 2019
Here are the top 5 CURE stories for July 2019.
BY Jessica Skarzynski
PUBLISHED August 01, 2019
Here are the top 5 CURE stories for July 2019.
5. If Only We Could Freeze Time
Sometimes, life is good and you just want to hit the pause button to enjoy it as much as you can. Here, CURE contributor Jane Biehl writes about how her partial remission makes her want to “freeze time” and prevent change from happening.
4. Biosimilar Approval Offers Options in Blood Cancer
In this story, we cover the FDA’s approval of Ruxience, which could offer a more affordable treatment option for patients with certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
3. A Patient-Turned-Caregiver Shares Her Story
Karen, who received a bladder cancer diagnosis in 2010, was faced with a similar challenge after her husband was diagnosed with the same disease just six years later. Learn more about her experience in this piece.
2. FDA Calls for Breast Implants to Be Recalled
After much debate, earlier this month the FDA requested that the manufacturer of a certain type of implant recall the product to protect women from potential risks, including breast implant-associated lymphoma. Read more in this breaking news coverage.
1. Life Is for Living
Have an adventure, buy the shoes and eat the cake. Here, a patient with glioblastoma shares her thoughts on why she doesn’t let a terminal diagnosis keep her from living her life.
5. If Only We Could Freeze Time
Sometimes, life is good and you just want to hit the pause button to enjoy it as much as you can. Here, CURE contributor Jane Biehl writes about how her partial remission makes her want to “freeze time” and prevent change from happening.
4. Biosimilar Approval Offers Options in Blood Cancer
In this story, we cover the FDA’s approval of Ruxience, which could offer a more affordable treatment option for patients with certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
3. A Patient-Turned-Caregiver Shares Her Story
Karen, who received a bladder cancer diagnosis in 2010, was faced with a similar challenge after her husband was diagnosed with the same disease just six years later. Learn more about her experience in this piece.
2. FDA Calls for Breast Implants to Be Recalled
After much debate, earlier this month the FDA requested that the manufacturer of a certain type of implant recall the product to protect women from potential risks, including breast implant-associated lymphoma. Read more in this breaking news coverage.
1. Life Is for Living
Have an adventure, buy the shoes and eat the cake. Here, a patient with glioblastoma shares her thoughts on why she doesn’t let a terminal diagnosis keep her from living her life.
Talk about this article with other patients, caregivers, and advocates in the Breast Cancer CURE discussion group.